Hepatitis C virus and disrupted interferon signaling promote lymphoproliferation via type II CD95 and interleukins
about
Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impactHepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?Direct effects of hepatitis C virus on the lymphoid cellsPersistent expression of the full genome of hepatitis C virus in B cells induces spontaneous development of B-cell lymphomas in vivo.Hepatitis C infection and lymphoproliferative disease: accidental comorbidities?Hepatitis C virus-related lymphomagenesis in a mouse model.M2 Macrophages Play Critical Roles in Progression of Inflammatory Liver Disease in Hepatitis C Virus Transgenic Mice.Etiological factors in primary hepatic B-cell lymphoma.Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention.Plasmablastic lymphoma of the retroperitoneum in an HIV- and HCV-positive patient: hard to diagnose and harder to treat.HCV and lymphoproliferation.Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection.Hepatitis C virus inhibits DNA damage repair through reactive oxygen and nitrogen species and by interfering with the ATM-NBS1/Mre11/Rad50 DNA repair pathway in monocytes and hepatocytesFrom the pathogenesis to the cure of indolent B-cell lymphoproliferative disorders associated with hepatitis C virus infection: which role for direct-acting antivirals?Notch4 and mhc class II polymorphisms are associated with hcv-related benign and malignant lymphoproliferative diseases.Hepatitis C virus and GBV-C virus prevalence among patients with B-cell lymphoma in different European regions: a case-control study of the International Extranodal Lymphoma Study Group.Liver cancer and non-Hodgkin lymphoma in hepatitis C virus-infected patients: results from the DANVIR cohort study.
P2860
Q22299128-39B41632-2734-4D7D-9B0D-A963E0BB45A5Q26750997-CDF331F2-0521-4ED4-8AED-F02F9BC5517EQ26992142-FEEDFB2B-8178-4B53-B082-B2454FC8655EQ34450690-0A8394F1-A64C-43E8-8C1C-5C0AAC77CC4DQ34552105-E10D22E3-E1AF-49D2-8607-0B55378F3389Q35367483-70ABA3FA-2086-4BDD-831D-C2DF65FFA883Q35807914-85AE3E61-01FA-4EDB-B0BE-578EE0971CA8Q35873839-4334B509-B002-4432-A2EA-2409144BEC3BQ37810431-177C76F4-427A-4AC7-95A6-EE09038049F0Q38007862-740C1C47-A900-4CD6-982A-F14776D54EFCQ38031228-1134397C-DC31-41C3-AC8B-D85664F31376Q38298448-B295AF60-5990-4E14-B622-D318C04E2F71Q39639979-B1951FD4-3948-4335-813B-19C729455C34Q40135838-5BD7887E-5B53-473D-9EE2-F11D30BC3AF5Q42700930-D5747839-4A66-44ED-B091-782EEE569ED9Q43048170-2B64FE96-1DCD-4EDF-9B73-7D8D5DFDFEC0Q43409999-92D3D5AA-6901-4322-A299-EC480A3361A4
P2860
Hepatitis C virus and disrupted interferon signaling promote lymphoproliferation via type II CD95 and interleukins
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Hepatitis C virus and disrupte ...... type II CD95 and interleukins
@ast
Hepatitis C virus and disrupte ...... type II CD95 and interleukins
@en
Hepatitis C virus and disrupte ...... type II CD95 and interleukins
@nl
type
label
Hepatitis C virus and disrupte ...... type II CD95 and interleukins
@ast
Hepatitis C virus and disrupte ...... type II CD95 and interleukins
@en
Hepatitis C virus and disrupte ...... type II CD95 and interleukins
@nl
prefLabel
Hepatitis C virus and disrupte ...... type II CD95 and interleukins
@ast
Hepatitis C virus and disrupte ...... type II CD95 and interleukins
@en
Hepatitis C virus and disrupte ...... type II CD95 and interleukins
@nl
P2093
P2860
P1433
P1476
Hepatitis C virus and disrupte ...... type II CD95 and interleukins
@en
P2093
Chyoji Taya
Eiji Seike
Hidemi Takahashi
Hiromichi Yonekawa
Kyoko Tsukiyama-Kohara
Masumi Shimizu
Michinori Kohara
Nobuyuki Tanaka
Satoshi Sekiguch
Shigenobu Tóne
P2860
P304
285-96, 296.e1-11
P356
10.1053/J.GASTRO.2009.03.061
P407
P577
2009-04-09T00:00:00Z